Altria suffers Juul troubles in first half of 2022 at ‘pivotal point’ in the industry

Altria is pessimistic about the future of Juul and its investment in the company but does not think the time has come to pull the plug just yet.

The US tobacco company does see the near future as absolutely pivotal to the make-up of tobacco alternatives in the country and has said it is up to the US Food and Drug Administration (FDA) to make the right calls on authorisations to allow products on the market.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us